129 related articles for article (PubMed ID: 28886236)
1. Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection.
Growková K; Kryukova E; Kufová Z; Filipová J; Ševčíková T; Říhová L; Kaščák M; Kryukov F; Hájek R
Eur J Haematol; 2017 Dec; 99(6):469-478. PubMed ID: 28886236
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
San Miguel JF; Vidriales MB; Ocio E; Mateo G; Sánchez-Guijo F; Sánchez ML; Escribano L; Bárez A; Moro MJ; Hernández J; Aguilera C; Cuello R; García-Frade J; López R; Portero J; Orfao A
Semin Oncol; 2003 Apr; 30(2):187-95. PubMed ID: 12720134
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic features by multiparameter flow cytometry can help distinguish low grade B-cell lymphomas with plasmacytic differentiation from plasma cell proliferative disorders with an unrelated clonal B-cell process.
Rosado FG; Morice WG; He R; Howard MT; Timm M; McPhail ED
Br J Haematol; 2015 May; 169(3):368-76. PubMed ID: 25644063
[TBL] [Abstract][Full Text] [Related]
5. The cellular origin and malignant transformation of Waldenström macroglobulinemia.
Paiva B; Corchete LA; Vidriales MB; García-Sanz R; Perez JJ; Aires-Mejia I; Sanchez ML; Barcena P; Alignani D; Jimenez C; Sarasquete ME; Mateos MV; Ocio EM; Puig N; Escalante F; Hernández J; Cuello R; García de Coca A; Sierra M; Montes MC; González-López TJ; Galende J; Bárez A; Alonso J; Pardal E; Orfao A; Gutierrez NC; San Miguel JF
Blood; 2015 Apr; 125(15):2370-80. PubMed ID: 25655603
[TBL] [Abstract][Full Text] [Related]
6. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Burnworth B; Wang Z; Singleton TP; Bennington A; Fritschle W; Bennington R; Brodersen LE; Wells DA; Loken MR; Zehentner BK
Leuk Res; 2016 Dec; 51():41-48. PubMed ID: 27890075
[TBL] [Abstract][Full Text] [Related]
7. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.
Remstein ED; Hanson CA; Kyle RA; Hodnefield JM; Kurtin PJ
Semin Oncol; 2003 Apr; 30(2):182-6. PubMed ID: 12720133
[TBL] [Abstract][Full Text] [Related]
8. Clonal B cells in Waldenström's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling.
Argyropoulos KV; Vogel R; Ziegler C; Altan-Bonnet G; Velardi E; Calafiore M; Dogan A; Arcila M; Patel M; Knapp K; Mallek C; Hunter ZR; Treon SP; van den Brink MR; Palomba ML
Leukemia; 2016 May; 30(5):1116-25. PubMed ID: 26867669
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
[TBL] [Abstract][Full Text] [Related]
10. Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level.
García-Sanz R; García-Álvarez M; Medina A; Askari E; González-Calle V; Casanova M; de la Torre-Loizaga I; Escalante-Barrigón F; Bastos-Boente M; Bárez A; Vidaña-Bedera N; Alonso JM; Sarasquete ME; González M; Chillón MC; Alcoceba M; Jiménez C
Dis Model Mech; 2023 Aug; 16(8):. PubMed ID: 37493341
[TBL] [Abstract][Full Text] [Related]
11. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
Owen RG
Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
[TBL] [Abstract][Full Text] [Related]
12. Origin of Waldenstrom's macroglobulinaemia.
García-Sanz R; Jiménez C; Puig N; Paiva B; Gutiérrez NC; Rodríguez-Otero P; Almeida J; San Miguel J; Orfão A; González M; Pérez-Andrés M
Best Pract Res Clin Haematol; 2016 Jun; 29(2):136-147. PubMed ID: 27825459
[TBL] [Abstract][Full Text] [Related]
13. Transitions in CD45 isoform expression indicate continuous differentiation of a monoclonal CD5+ CD11b+ B lineage in Waldenstrom's macroglobulinemia.
Jensen GS; Andrews EJ; Mant MJ; Vergidis R; Ledbetter JA; Pilarski LM
Am J Hematol; 1991 May; 37(1):20-30. PubMed ID: 1708944
[TBL] [Abstract][Full Text] [Related]
14. IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormality.
Chehal A; Taher A; Shamseddine A
Clin Lab Haematol; 2003 Jun; 25(3):187-90. PubMed ID: 12755797
[TBL] [Abstract][Full Text] [Related]
15. Sequence and expression analyses of mu and delta transcripts in patients with Waldenström's macroglobulinemia.
Shiokawa S; Suehiro Y; Uike N; Muta K; Nishimura J
Am J Hematol; 2001 Nov; 68(3):139-43. PubMed ID: 11754393
[TBL] [Abstract][Full Text] [Related]
16. Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: an evolving concept.
Lin P; Medeiros LJ
Adv Anat Pathol; 2005 Sep; 12(5):246-55. PubMed ID: 16210920
[TBL] [Abstract][Full Text] [Related]
17. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
18. Intraclonal heterogeneity in concomitant monoclonal lymphocyte and plasma cell populations: combining flow cytometric cell sorting with molecular monoclonality profiling.
Zehentner BK; de Baca ME; Wells DA; Loken MR
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):214-7. PubMed ID: 23490988
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
20. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.
Sahota SS; Forconi F; Ottensmeier CH; Stevenson FK
Semin Oncol; 2003 Apr; 30(2):136-41. PubMed ID: 12720123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
